Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer von Tewari, Krishnansu S, Burger, Robert A, Enserro, Danielle, Norquist, Barbara M, Swisher, Elizabeth M, Brady, Mark F, Bookman, Michael A, Fleming, Gini F, Huang, Helen, Homesley, Howard D, Fowler, Jeffrey M, Greer, Benjamin E, Boente, Matthew, Liang, Sharon X, Ye, Chenglin, Bais, Carlos, Randall, Leslie M, Chan, John K, Ferriss, J Stuart, Coleman, Robert L, Aghajanian, Carol, Herzog, Thomas J, DiSaia, Philip J, Copeland, Larry J, Mannel, Robert S, Birrer, Michael J, Monk, Bradley J

Volltext

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer von Burger, Robert A, Brady, Mark F, Bookman, Michael A, Fleming, Gini F, Monk, Bradley J, Huang, Helen, Mannel, Robert S, Homesley, Howard D, Fowler, Jeffrey, Greer, Benjamin E, Boente, Matthew, Birrer, Michael J, Liang, Sharon X

Volltext

The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium von Fadare, Oluwole, Gwin, Katja, Desouki, Mohamed M, Crispens, Marta A, Jones, Howard W, Khabele, Dineo, Liang, Sharon X, Zheng, Wenxin, Mohammed, Khaled, Hecht, Jonathan L, Parkash, Vinita

Volltext

Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study von BURGER, Robert A, BRADY, Mark F, LIM, Peter C, RUBIN, Stephen C, KATSUMATA, Noriyuki, LIANG, Sharon X, BOOKMAN, Michael A, MONK, Bradley J, WALKER, Joan L, HOMESLEY, Howard D, FOWLER, Jeffrey, GREER, Benjamin E, BOENTE, Matthew, FLEMING, Gini F

Volltext

Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: A Gynecologic Oncology Group Study von Monk, Bradley J, Huang, Helen Q, Burger, Robert A, Mannel, Robert S, Homesley, Howard D, Fowler, Jeffrey, Greer, Benjamin E, Boente, Matthew, Liang, Sharon X, Wenzel, Lari

Volltext

Expression of the oncofetal protein IGF2BP3 in endometrial clear cell carcinoma: assessment of frequency and significance von Fadare, Oluwole, MD, Liang, Sharon X., MD, PhD, Crispens, Marta A., MD, Jones, Howard W., MD, Khabele, Dineo, MD, Gwin, Katja, MD, PhD, Zheng, Wenxin, MD, Mohammed, Khaled, MD, Parkash, Vinita, MD, Hecht, Jonathan L., MD, PhD, Desouki, Mohamed M., MD, PhD

Volltext

Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot Assessment von Fadare, Oluwole, Renshaw, Idris L, Liang, Sharon X

Volltext

The significance of L1CAM expression in clear cell carcinoma of the endometrium von Fadare, Oluwole, Roma, Andres A, Desouki, Mohamed M, Gwin, Katja, Hanley, Krisztina Z, Jarboe, Elke A, Liang, Sharon X, Quick, Charles M, Zheng, Wenxin, Hecht, Jonathan L, Parkash, Vinita, Wang, Xuan J

Volltext

Utility of α -methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas von Fadare, Oluwole, MD, Parkash, Vinita, MD, Gwin, Katja, MD, PhD, Hanley, Krisztina Z., MD, Jarboe,, Elke A., MD, Liang, Sharon X., MD, PhD, Quick, Charles M., MD, Zheng, Wenxin, MD, Rawish, Kojo R., MD, PhD, Hecht, Jonathan L., MD, PhD, Desouki, Mohamed M., MD, PhD

Volltext

Precursors of endometrial clear cell carcinoma von FADARE, Oluwole, LIANG, Sharon X, ULUKUS, E. Cagnur, CHAMBERS, Setsuko K, WENXIN ZHENG

Volltext

Mesonephric Adenocarcinoma and Mesonephric-like Adenocarcinoma of the Urinary Tract von Xing, Deyin, Liang, Sharon X, Gao, Faye F, Epstein, Jonathan I

Volltext

Are clear cell carcinomas of the ovary and endometrium phenotypically identical? A proteomic analysis von Fata, Cynthia R., MD, MSPH, Seeley, Erin H., PhD, Desouki, Mohamed M., MD, PhD, Du, Liping, PhD, Gwin, Katja, MD, PhD, Hanley, Krisztina Z., MD, Hecht, Jonathan L., MD, PhD, Jarboe, Elke A., MD, Liang, Sharon X., MD, PhD, Parkash, Vinita, MD, Quick, Charles M., MD, Zheng, Wenxin, MD, Shyr, Yu, PhD, Caprioli, Richard M., PhD, Fadare, Oluwole, MD

Volltext

Molecular Identification of “Latent Precancers” for Endometrial Serous Carcinoma in Benign-Appearing Endometrium von Zhang, Xi, Liang, Sharon X, Jia, Lin, Chen, Ning, Fadare, Oluwole, Schwartz, Peter E, Kong, Beihua, Zheng, Wenxin

Volltext

Assessment of the Utility of PAX8 Immunohistochemical Stain in Diagnosing Endocervical Glandular Lesions von Liang, Li, Zheng, Wenxin, Liu, Jinsong, Liang, Sharon X

Volltext

Solid pseudopapillary neoplasm presenting as a primary ovarian mass in an eighteen-year-old female: report of a case and review of the literature von Komforti, Miglena K., Edelman, Morris, Fan, Cathy, Liang, Sharon X.

Volltext

Frequent Expression of Napsin A in Clear Cell Carcinoma of the Endometrium: Potential Diagnostic Utility von Fadare, Oluwole, Desouki, Mohamed M, Gwin, Katja, Hanley, Krisztina Z, Jarboe, Elke A, Liang, Sharon X, Quick, Charles M, Zheng, Wenxin, Parkash, Vinita, Hecht, Jonathan L

Volltext

The Oncofetal Protein IMP3 : A Novel Biomarker for Endometrial Serous Carcinoma von WENXIN ZHENG, XIAOFANG YI, FADARE, Oluwole, LIANG, Sharon X, MARTEL, Maritza, SCHWARTZ, Peter E, ZHONG JIANG

Volltext

Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid cell tumors von Fadare, Oluwole, MD, Liang, Sharon X., MD, PhD

Volltext

Metastatic Malignant Ovarian Steroid Cell Tumor: A Case Report and Review of the Literature von D’Agostino, Catherine A., Liang, Sharon X., John, Veena S., Lee, Jessica, Menzin, Andrew W.

Volltext

Endometrial Glandular Dysplasia: A Newly Defined Precursor Lesion of Uterine Papillary Serous Carcinoma. Part I: Morphologic Features von Zheng, Wenxin, Liang, Sharon X., Yu, Herbert, Rutherford, Thomas, Chambers, Setsuko K., Schwartz, Peter E.

Volltext